CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in SABS — SAB Biotherapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$412,159

+$400,988 QoQ

Shares Held

105,682

+6407.5% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 86 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. SABS ranks #265 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$412,159	105,682	+550.8%	Shares	Sole	2026-08-14
2023-12-31	$11,171	16,238	0.0%	Shares	Sole	2024-02-06
2023-09-30	$10,229	16,238	0.0%	Shares	Sole	2023-11-08
2023-06-30	$13,477	16,238	0.0%	Shares	Sole	2023-08-10
2023-03-31	$7,144	16,238	0.0%	Shares	Sole	2023-05-12
2022-12-31	$9,580	16,238	0.0%	Shares	Sole	2023-02-13
2022-09-30	$11,382	16,238	0.0%	Shares	Sole	2022-11-14
2022-06-30	$23,545	16,238	+62.4%	Shares	Sole	2022-08-15
2021-12-31	$78,100	10,000	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.